Metropolitan Life Insurance Co. NY maintained its position in shares of LHC Group (NASDAQ:LHCG) during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 10,150 shares of the health services provider’s stock at the end of the first quarter. Metropolitan Life Insurance Co. NY’s holdings in LHC Group were worth $547,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently made changes to their positions in the stock. Iguana Healthcare Management LLC increased its stake in shares of LHC Group by 16.7% in the first quarter. Iguana Healthcare Management LLC now owns 35,000 shares of the health services provider’s stock worth $1,887,000 after buying an additional 5,000 shares during the last quarter. State Street Corp increased its stake in shares of LHC Group by 4.7% in the first quarter. State Street Corp now owns 391,375 shares of the health services provider’s stock worth $21,095,000 after buying an additional 17,439 shares during the last quarter. Bank of America Corp DE increased its stake in shares of LHC Group by 123.5% in the first quarter. Bank of America Corp DE now owns 34,658 shares of the health services provider’s stock worth $1,868,000 after buying an additional 19,154 shares during the last quarter. Schwab Charles Investment Management Inc. increased its stake in shares of LHC Group by 7.0% in the first quarter. Schwab Charles Investment Management Inc. now owns 84,338 shares of the health services provider’s stock worth $4,546,000 after buying an additional 5,551 shares during the last quarter. Finally, Invictus RG bought a new stake in shares of LHC Group during the first quarter worth $125,000. Hedge funds and other institutional investors own 84.97% of the company’s stock.

Shares of LHC Group (NASDAQ LHCG) traded up 1.11% during midday trading on Friday, reaching $63.86. The company had a trading volume of 28,819 shares. The company’s 50 day moving average price is $63.76 and its 200-day moving average price is $56.72. LHC Group has a 52 week low of $32.04 and a 52 week high of $69.35. The company has a market capitalization of $1.17 billion, a P/E ratio of 28.26 and a beta of 0.77.

LHC Group (NASDAQ:LHCG) last issued its quarterly earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.54 by $0.09. LHC Group had a return on equity of 9.62% and a net margin of 4.13%. The company had revenue of $260.20 million for the quarter, compared to the consensus estimate of $254.10 million. During the same quarter in the prior year, the business earned $0.52 EPS. LHC Group’s revenue was up 15.1% on a year-over-year basis. On average, equities research analysts predict that LHC Group will post $2.39 earnings per share for the current fiscal year.

WARNING: “Metropolitan Life Insurance Co. NY Has $547,000 Stake in LHC Group (NASDAQ:LHCG)” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this news story on another website, it was stolen and republished in violation of US & international copyright & trademark laws. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/08/11/metropolitan-life-insurance-co-ny-has-547000-stake-in-lhc-group-nasdaqlhcg.html.

A number of equities research analysts recently weighed in on the company. Stephens set a $69.00 price objective on LHC Group and gave the company a “buy” rating in a research report on Saturday, May 6th. Zacks Investment Research raised LHC Group from a “hold” rating to a “buy” rating and set a $67.00 price objective on the stock in a research report on Saturday, August 5th. Jefferies Group LLC reaffirmed a “buy” rating and set a $68.00 price objective on shares of LHC Group in a research report on Friday, August 4th. Benchmark Co. raised their price objective on LHC Group from $63.00 to $72.00 and gave the company a “buy” rating in a research report on Thursday, June 8th. Finally, BidaskClub downgraded LHC Group from a “buy” rating to a “hold” rating in a research report on Tuesday, July 25th. One research analyst has rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $65.75.

In other LHC Group news, Director Coliseum Capital Management, L sold 107,463 shares of the company’s stock in a transaction dated Tuesday, May 30th. The stock was sold at an average price of $60.63, for a total transaction of $6,515,481.69. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Donald Dwayne Stelly sold 3,181 shares of the company’s stock in a transaction dated Thursday, June 8th. The stock was sold at an average price of $64.97, for a total value of $206,669.57. Following the sale, the chief operating officer now owns 114,235 shares in the company, valued at approximately $7,421,847.95. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 554,839 shares of company stock worth $34,333,811. 14.80% of the stock is owned by company insiders.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group (NASDAQ:LHCG).

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.